30 July 2026

Clinical Diabetes Obesity Pharmaceuticals

Tirzepatide dose reduction and the impact on long-term maintenance of weight loss

10 July 2026

Clinical Diabetes Diet

Onion lovers could have lower risk of T2D

7 July 2026

Clinical research Diabetes

GP-led CGMs cut hospital visits for diabetes patients

30 June 2026

Clinical research Diabetes Obesity Pharmaceuticals

Triple hormone receptor agonist improves glycaemic control and bodyweight reduction in T2D

19 June 2026

Clinical Diabetes Obesity Pharmaceuticals

Tirzepatide KwikPen update: Practical guidance for clinicians

11 June 2026

Clinical Diabetes Obesity Pharmaceuticals

How do people feel about using GLP-1 RAs?

9 June 2026

Diabetes Political

Anti-MAHA docs kicked out of American Diabetes Association conference

5 June 2026

Clinical Diabetes

Coming up: Practical guide to improving control of T2D

4 June 2026

Clinical research Diabetes Respiratory

Diabetes doubles down on bronchiectasis burden

27 May 2026

Diabetes Pharmaceuticals

TGA green light for first drug to slow type 1 diabetes

4 May 2026

Cardiovascular Diabetes Obesity Research

A potential new way to target excess glycogen stores

25 April 2026

Diabetes Pharmaceuticals

PBAC says yes to tirzepatide for T2D – but Lilly says no

10 April 2026

Clinical Diabetes Research

Diabetes referrals lost in the fog says new study

2 April 2026

Clinical Diabetes Pharmaceuticals

An update on semaglutide for CKD in the presence of T2D

10 March 2026

Clinical Diabetes Renal

Coming up: the role of GLP-1 in the management of CKD in T2D

27 February 2026

Diabetes Pharmaceuticals TGA

Two oral GLP-1 RAs go head-to-head